Targeted Approach Succeeds in Pancreatic Cancer
- PMID: 32273294
- DOI: 10.1158/2159-8290.CD-NB2020-026
Targeted Approach Succeeds in Pancreatic Cancer
Abstract
Matching patients with pancreatic cancer to therapies based on genomic alterations in their tumors may be beneficial. In the retrospective Know Your Tumor trial, patients with alterations who were treated with targeted agents lived longer than those treated with standard therapies.
©2020 American Association for Cancer Research.
Comment on
-
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.Clin Cancer Res. 2018 Oct 15;24(20):5018-5027. doi: 10.1158/1078-0432.CCR-18-0531. Epub 2018 Jun 28. Clin Cancer Res. 2018. PMID: 29954777
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
